Quick Research
Filters Clear All
Any Time
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 25,274 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
SNAI1 promotes epithelial-mesenchymal transition and maintains cancer stem cell-like properties in thymic epithelial tumors through the PIK3R2/p-EphA2 Axis (2024-12-19)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.4 -
RPTOR blockade suppresses brain metastases of NSCLC by interfering the ceramide metabolism via hijacking YY1 binding (2024-01-02)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: Mouse Astrocyte cells -
A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells (2024-01-02)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: A875 [A-875] Cells Line, 293T [HEK-293T] Cells Line, SK-MEL-28 Cells Line -
EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance (2024-01-02)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: DMEM/F12, Ham's F-12K, RPMI-1640, DMEM(High glucose), Penicillin-Streptomycin Solution, 100× -
MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation (2024-01-25)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: KATO III [KATO 3] Cells Line -
FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer (2024-01-29)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: NCI-H1299 Cells Line, A549 [A-549] Cells Line, Fetal Bovine Serum -
A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity (2024-02-21)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: hFOB 1.19 Cells Line, DMEM/F12 (with HEPES) Complete Medium (10) -
Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer (2024-02-26)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: NIH:OVCAR-3 [OVCAR3] Cells Line, SK-OV-3 Cells Line, McCoy's 5A -
Blocking the MIF-CD74 axis augments radiotherapy efficacy for brain metastasis in NSCLC via synergistically promoting microglia M1 polarization (2024-04-29)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: BV2 (DMEM) Cells Line -
Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression (2024-04-23)
Journal: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2024) IF: 11.3Products Cited: NCI-H1299 Cells Line, NCI-H460 [H460] Cells Line, Fetal Bovine Serum, A549 [A-549] Cells Line, SK-MES-1 Cells Line, BEAS-2B Cells Line, 293T [HEK-293T] Cells Line, NCI-H226 [H226] Cells Line
